These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19343079)

  • 1. Signalosomes as Therapeutic Targets.
    Negro A; Dodge-Kafka K; Kapiloff MS
    Prog Pediatr Cardiol; 2008 Apr; 25(1):51-56. PubMed ID: 19343079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mAKAPβ signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling.
    Dodge-Kafka K; Gildart M; Tokarski K; Kapiloff MS
    Cell Signal; 2019 Nov; 63():109357. PubMed ID: 31299211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
    Golatkar V; Bhatt LK
    Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mAKAP signalosome and cardiac myocyte hypertrophy.
    Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
    IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mAKAP-a master scaffold for cardiac remodeling.
    Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
    Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
    Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
    J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
    Li J; Negro A; Lopez J; Bauman AL; Henson E; Dodge-Kafka K; Kapiloff MS
    J Mol Cell Cardiol; 2010 Feb; 48(2):387-94. PubMed ID: 19883655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
    Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
    Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel molecular targets in the treatment of cardiac hypertrophy.
    Luedde M; Katus HA; Frey N
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):1-20. PubMed ID: 18221071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling].
    Coppini R; Ferrantini C; Poggesi C; Mugelli A; Olivotto I
    G Ital Cardiol (Rome); 2016 Mar; 17(3):189-96. PubMed ID: 27029877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
    Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
    Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy.
    Takano H; Zou Y; Akazawa H; Toko H; Mizukami M; Hasegawa H; Asakawa M; Nagai T; Komuro I
    Hypertens Res; 2002 Jul; 25(4):491-8. PubMed ID: 12358132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
    Gallo S; Vitacolonna A; Bonzano A; Comoglio P; Crepaldi T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
    Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocyte hypertrophy and apoptosis: a balancing act.
    van Empel VP; De Windt LJ
    Cardiovasc Res; 2004 Aug; 63(3):487-99. PubMed ID: 15276474
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.